3 Studies on Major Depressive Disorder: Physical, Pharmacologic, and Neuromodulatory Interventions Explored
Findings on the efficacy of treatments for MDD include the favorable effects of exercise, of CBT, and the robust outcomes of ECT among neuromodulatory modalities.
The 3 recent studies reviewed here explore some of the primary interventions in wide use for treatment of major depressive disorder (MDD) and their efficacy. MDD is estimated to affect more than 21 million US adults, roughly 8.4% of the population aged 18 years and older.1 Research shows, however, that nearly half of those with MDD are not receiving treatment1 and of those who are being treated, approximately one-third have treatment resistant disease.2
Among the findings reported across these 3 studies are a 33% to 43% reduction in onset of MDD among people who engaged in cognitive behavioral therapy, the superiority of electroconvulsive therapy to other neurmodulatory interventions for treatment resistant depression, and the comparative effects of different types of exercise on clinical depression and outcomes by demographics. Links are provided to the full papers for each for additional reading.
References
1. Depression facts and statistics. Anxiety and Depression Association of America. Updated November 3, 2023. https://adaa.org/understanding-anxiety/depression/facts-statistics
2. Zhdanava M, Pilon D, Ghelerter I, et al. The prevalence and national burden of treatment resistant depression and major depressive disorder in the United States. J Clin Psychiatr. 2021;82(2):20m13699. doi:10.4088/JCP.20m13699
FDA Approves Esketamine as Monotherapy for Adults With Treatment-Resistant Depression
January 21st 2025The approval of esketamine follows an FDA Priority Review and is based on data showing that esketamine alone demonstrated rapid and superior improvement in depressive symptoms compared with placebo.
Podcast: Arthritis, Anxiety, and Depression: Managing a Common Comorbidity
May 14th 2012Anxiety is even more common than depression among people who have arthritis, a new study has shown. Here to discuss the implications for diagnosis and treatment is Eilzabeth Lin MD, a family medicine physician who is a longstanding researcher in the field of depression and pain.
